IVD Medical Holding Limited (HKG:1931)
8.64
-0.58 (-6.29%)
Sep 30, 2025, 4:08 PM HKT
IVD Medical Holding Revenue
IVD Medical Holding had revenue of 1.27B CNY in the half year ending June 30, 2025, a decrease of -7.82%. This brings the company's revenue in the last twelve months to 3.08B, up 0.46% year-over-year. In the year 2024, IVD Medical Holding had annual revenue of 3.16B with 2.40% growth.
Revenue (ttm)
3.08B CNY
Revenue Growth
+0.46%
P/S Ratio
4.15
Revenue / Employee
3.57M CNY
Employees
863
Market Cap
13.98B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.16B | 74.03M | 2.40% |
Dec 31, 2023 | 3.09B | 339.58M | 12.35% |
Dec 31, 2022 | 2.75B | 18.14M | 0.66% |
Dec 31, 2021 | 2.73B | 302.46M | 12.46% |
Dec 31, 2020 | 2.43B | 95.47M | 4.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
WuXi Biologics | 21.98B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
Akeso | 2.75B |
Sichuan Kelun-Biotech Biopharmaceutical | 1.64B |